2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Major Innovations Are Driving the Accelerated Growth of the Theranostics Market?
The increase in cancer cases is anticipated to fuel the theranostics market’s expansion. Cancer is a disease characterized by uncontrolled cell proliferation that affects various organs, causing substantial morbidity and mortality globally. Theranostics, a fusion of therapeutics and diagnostics, holds significant promise for managing cancer and chronic illnesses. This strategy enables customised and targeted therapies by merging diagnostic and therapeutic capabilities, bringing potential for innovation in the health sector. Therefore, the growing cancer patient population is anticipated to boost the theranostics market. For example, in January 2022, the National Cancer Institute (NCI), a US government agency part of the National Institutes of Health (NIH), dedicated to cancer research, prevention and treatment, reported that about 5.4% or 18.1 million individuals in the USA are cancer survivors. Furthermore, in 2022, there were 623,405 individuals diagnosed with metastatic breast, prostate, lung, colorectal, or bladder cancer or metastatic melanoma, a figure anticipated to increase to 693,452 by 2025. Consequently, the escalating incidence of cancer is propelling the theranostics market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10823&type=smp
#What is the Anticipated CAGR of theTheranostics Market, and What Factors Will Drive It?
In recent times, the theranostics market has witnessed rapid expansion. The market is forecasted to increase from $111.1 billion in 2024 to $123.33 billion in 2025, with a compound annual growth rate (CAGR) of 11.0%. The historical growth of the sector is due to progress in molecular imaging, a transition towards value-based healthcare, and integration within oncology.
In the coming years, the theranostics market is predicted to exhibit swift expansion, reaching a size of $185.73 billion by 2029, compounded annually at 10.8%. Factors leading to this surge during the forecasted timeframe include an increase in precision medicine initiatives, the extended use of theranostics beyond oncology, population aging coupled with chronic diseases, breakthroughs in biomarker discovery, and governmental backing and funding. Trending factors during the forecasted period encompass regulatory support, the ascension of companion diagnostics, a heightened emphasis on cancer theranostics, enhanced patient involvement and awareness, and the merging of technology.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10823
What Are the Most Significant Market Trends Transforming theTheranostics Market?
Major firms in the theranostics industry are prioritizing the development of technologically superior solutions such as theranostics clinical trials. These efforts are aimed at boosting personalized medicine and enhancing patient results by combining diagnostic and therapeutic aspects into a single treatment approach. Theranostics clinical trials are designed to analyze and determine the combination of diagnostic tests and targeted therapies that are most effective for individual patients, thus expanding the realm of personalized medicine. For instance, BAMF Health, a cancer treatment leader based in the U.S., initiated the COMBAT Trial in May 2024. This officially titled “A Phase I/II Theranostic Study of 64Cu-SAR-BBN and 67Cu-SAR-BBN for Identification and Treatment of GRPR-expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617” (NCT05633160), was rapidly activated through BAMF Health’s BAMF RapAct program allowing the trial to kick off in just seven weeks. The trial particularly emphasizes the use of unique radiopharmaceuticals that target the Gastrin-Releasing Peptide receptor (GRPR), with the aim to extend treatment possibilities for patients with limited therapeutic options.
What Are the Top Market Players Propelling the Growth of theTheranostics Industry?
Major companies operating in the theranostics market include Abbott Laboratories, Agilent Technologies Inc., AmeriPath Inc, Beckman Coulter Inc., Thermo Fisher Scientific Inc, Astellas Pharma, Helmholtz Centre for Infection Research, Radiopharm Theranostics Ltd, Alpha- Theranostics, UNIVERZITET U NOVOM SADU, Cardio-Theranostics LLC, Curium, SoFi Technologies Inc., Theradiag, Cell Theranostics, F. Hoffmann-La Roche AG, GE HealthCare Technologies Inc, Qiagen NV, Foundation Medicine Inc, Leica Biosystems Nussloch GmBH, Pfizer Inc., Siemens Healthineers, Advanced Accelerator Applications, AstraZeneca plc, Bayer AG, Bio-Rad Laboratories, The Bristol-Myers Squibb Company, Danaher Corporation, MilliporeSigma, Illumina Inc., Merck KGaA, Roche Diagnostics Corporation, PerkinElmer Inc.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/theranostics-global-market-report
Which Primary Segments of the Theranostics Market Are Driving Growth and Industry Transformations?
The theranostics market covered in this report is segmented –
1) By Disease Type: Neurological Disorders, Cardiovascular Diseases, Immunological Disorders, Oncology Diseases, Other Diseases
2) By Technology: Polymerase Chain Reaction, Immunohistochemistry, In-Situ Hybridization, Sequencing, Other Technologies
3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users
Subsegments:
1) By Neurological Disorders: Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Epilepsy, Other Neurological Disorders
2) By Cardiovascular Diseases: Coronary Artery Disease, Heart Failure, Atrial Fibrillation, Hypertension, Other Cardiovascular Diseases
3) By Immunological Disorders: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Inflammatory Bowel Disease, Psoriasis, Other Immunological Disorders
4) By Oncology Diseases: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Other Oncology Diseases
5) By Other Diseases: Infectious Diseases, Metabolic Disorders, Genetic Disorders, Other Diseases
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=10823&type=smp
Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the Theranostics Market?# Market?
North America was the largest region in the global theranostics market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the theranostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Gobal Theranostics Maret 2025, By The Business Research Company:
Aromatherapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/aromatherapy-global-market-report
Cancer Immunotherapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cancer-immunotherapy-global-market-report
Negative Pressure Wound Therapy Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
